CIK 0001386570 · Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262940963
- Phone
- 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-15 | Patrick Kristin Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-04-15 | Cohen Ann Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-03-16 | Fried Robert N CEO | Purchase | +25,000 | $2.16 | $54K | 88,001 |
| 2022-02-17 | Jaksch Frank L Jr EXECUTIVE CHAIRMAN OF BOARD | Grant or award · Employee Stock Options (right to buy) | +107,805 | 107,805 | ||
| 2022-02-17 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Options (right to buy) | +122,374 | 122,374 | ||
| 2022-02-17 | Fried Robert N CEO | Grant or award · Employee Stock Options (right to buy) | +240,448 | 240,448 | ||
| 2021-12-13 | Ng Wang Yu Gary Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2021-12-01 | Levy Caroline S Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2021-06-17 | Baxter Jeff Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2021-06-17 | LAU Tsz Ho Tony Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2021-06-17 | Rubin Steven D Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2021-06-17 | BLOCK STEPHEN A Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2021-06-17 | YU Wing Tak Wendy Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2021-06-17 | GUSTAFSON KURT A Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2021-05-13 | Fried Robert N CEO | Purchase | +10,000 | $6.65 | $67K | 63,001 |
| 2021-03-16 | BLOCK STEPHEN A Director | Option exercise | +20,000 | $2.61 | $52K | 36,667 |
| 2021-03-16 | BLOCK STEPHEN A Director | Sale | −20,000 | $13.17 | $263K | 16,667 |
| 2021-03-16 | BLOCK STEPHEN A Director | Option exercise · Stock Options (right to buy) | −20,000 | 0 | ||
| 2021-03-15 | Harrington Lisa Hatton GENERAL COUNSEL | Grant or award · Employee Stock Options (right to buy) | +15,000 | 15,000 | ||
| 2021-03-15 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Options (right to buy) | +28,461 | 28,461 |
Page 5 of 6 · 118 trades